Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Medicine Mindmed Inc (MMEDF)

Mind Medicine Mindmed Inc (MMEDF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MMEDF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4400 +129.55%
on 09/24/20
1.0900 -7.34%
on 10/21/20
+0.5368 (+113.44%)
since 09/23/20
3-Month
0.3000 +236.67%
on 07/27/20
1.0900 -7.34%
on 10/21/20
+0.6940 (+219.62%)
since 07/23/20

Most Recent Stories

More News
The Potential $100 Billion Psychedelics Boom Investors Should Watch

Much like cannabis, psychedelics are quickly going mainstream – and fast, most notably psilocybin. ...

RVVTF : 0.1729 (-4.48%)
HAVN.CN : 0.970 (+14.12%)
MMEDF : 1.0100 (+3.06%)
CMPS : 38.39 (+12.25%)
NUMI.VN : 0.425 (+11.84%)
JNJ : 145.24 (+0.11%)
RVV.CN : 0.225 (-4.26%)
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MMEDF : 1.0100 (+3.06%)
UPDATE - Trends in Psychedelic Drugs Research and Four Stocks You Should Know About

OTCStockReview.com News Commentary

EHVVF : 0.0365 (+35.19%)
CMPS : 38.39 (+12.25%)
MMEDF : 1.0100 (+3.06%)
Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics

, /PRNewswire/ -- Compelling evidence of the of psychedelic drugs appears in multiple scientific studies. Several are underway in and worldwide to investigate the therapeutic effects of psilocybin,...

CMPS : 38.39 (+12.25%)
MMEDF : 1.0100 (+3.06%)
FTRP.CN : 2.480 (-7.81%)
LKYSF : 0.3279 (+9.70%)
Compass Pathways' Historic IPO Shines Spotlight on Alternative Mental Health Treatments

, /PRNewswire/ -- Depression, anxiety, post-traumatic stress disorder (PTSD), and other mental illnesses have been prevalent in the US for quite some time, but the coronavirus pandemic has triggered a...

CMPS : 38.39 (+12.25%)
MMEDF : 1.0100 (+3.06%)
TNXP : 0.6666 (-1.04%)
NUMI.VN : 0.425 (+11.84%)
LKYSF : 0.3279 (+9.70%)
MYCO.CN : 0.235 (-4.08%)
MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

MMEDF : 1.0100 (+3.06%)
MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

MMEDF : 1.0100 (+3.06%)
Psilocybin Could be an Effective Treatment for Millions Battling Obesity

Psilocybin could soon help millions of people tackle obesity and eating disorders. After all, the ...

VEGGF : 0.0580 (+3.57%)
MMEDF : 1.0100 (+3.06%)
CMPS : 38.39 (+12.25%)
NUMI.VN : 0.425 (+11.84%)
HAVN.CN : 0.970 (+14.12%)
PLNT.CN : 0.075 (unch)
These Could be Some of the Most Valuable Psychedelic Stocks

Psychedelics, like psilocybin are going mainstream – and fast. Already, over the last few months, ...

CMPS : 38.39 (+12.25%)
RVVTF : 0.1729 (-4.48%)
MMEDF : 1.0100 (+3.06%)
NUMI.VN : 0.425 (+11.84%)
MCUR.CN : 0.740 (+4.23%)
HAVN.CN : 0.970 (+14.12%)
RVV.CN : 0.225 (-4.26%)
Compass Pathways' Leads the Way as the First Psychedelics Company To IPO on the Nasdaq

, /PRNewswire/ -- Last year may have been all about cannabis, but it's clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since (NYSE:JNJ) ketamine-derived medicine, Spravato,...

AGN : 193.02 (+0.02%)
RVVTF : 0.1729 (-4.48%)
JNJ : 145.24 (+0.11%)
CMPS : 38.39 (+12.25%)
RVV.CN : 0.225 (-4.26%)
ABBV : 84.34 (+0.04%)
MMEDF : 1.0100 (+3.06%)

Key Turning Points

2nd Resistance Point 1.0670
1st Resistance Point 1.0385
Last Price 1.0100
1st Support Level 0.9830
2nd Support Level 0.9560

See More

52-Week High 1.0900
Last Price 1.0100
Fibonacci 61.8% 0.7054
Fibonacci 50% 0.5867
Fibonacci 38.2% 0.4679
52-Week Low 0.0833

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar